New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2014
12:42 EDTCLVSClovis price target raised to $122 from $110 at Leerink
Leerink raised its price target for Clovis shares to $122 citing the company's "impressive" CO-1686 European Lung Cancer Conference data. The firm keeps an Outperform rating on the stock.
News For CLVS From The Last 14 Days
Check below for free stories on CLVS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 10, 2014
16:03 EDTCLVSClovis announces first patient enrolled in lucitanib Phase 2 study
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use